Evidence map›Paper›PMID 20543067›Full record

ArticleJournal of bacteriology2010

Genomic identification of a novel mutation in hfq that provides multiple benefits in evolving glucose-limited populations of Escherichia coli.

Ram Maharjan, Zhemin Zhou, Yan Ren, Yang Li, Joël Gaffé, Dominique Schneider, Christopher McKenzie, Peter R Reeves, Thomas Ferenci, Lei Wang

Abstract read
In one paragraph

Article in Journal of bacteriology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ram MaharjanSchool of Molecular Bioscience, University of Sydney, New South Wales, Australia.
Zhemin Zhou
Yan Ren
Yang Li
Joël Gaffé
Dominique Schneider
Christopher McKenzie
Peter R Reeves
Thomas Ferenci
Lei Wang

Funding

Microbiome and intestinal innate immune response in alcoholic liver diseaseR01AA020703 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SCHNABL, BERND G. · 2011 to 2020
$3.6M
NIAAA NIH HHS R01 AA020703
6 · The paper itself

Abstract

Beneficial mutations in diversifying glucose-limited Escherichia coli populations are mostly unidentified. The genome of an evolved isolate with multiple differences from that of the ancestor was fully assembled. Remarkably, a single mutation in hfq was responsible for the multiple benefits under glucose limitation through changes in at least five regulation targets.

Indexed as

Adaptation, PhysiologicalEvolution, MolecularGenome, BacterialMutationEscherichia coliEscherichia coli ProteinsGene Expression Regulation, BacterialGlucoseHost Factor 1 ProteinEscherichia coli ProteinsGlucoseHfq protein, E coliHost Factor 1 Protein

Identifiers

PMID20543067
PMCPMC2937378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.